Gabriel E. Dimattia
London, ON N6A3K7, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities.
Journal: Cells
Published: April 07, 2025
Spatiotemporal analysis of ratiometric biosensors in live multicellular spheroids using SPoRTS.
Journal: Cell reports methods
Published: September 05, 2024
Gain-of-function p53R175H blocks apoptosis in a precursor model of ovarian high-grade serous carcinoma.
Journal: Scientific reports
Published: March 05, 2023
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK Inhibition.
Journal: Molecular cancer therapeutics
Published: January 03, 2022
Loss of LKB1-NUAK1 signalling enhances NF-κB activity in a spheroid model of high-grade serous ovarian cancer.
Journal: Scientific reports
Published: September 30, 2021
MAIT cells accumulate in ovarian cancer-elicited ascites where they retain their capacity to respond to MR1 ligands and cytokine cues.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2021
Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C.
Journal: Cells
Published: October 05, 2020
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic Vulnerability.
Journal: Cancer research
Published: July 09, 2020
Inhibiting ULK1 kinase decreases autophagy and cell viability in high-grade serous ovarian cancer spheroids.
Journal: American journal of cancer research
Published: February 01, 2020
Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
Journal: Gynecologic oncology
Published: August 07, 2019
Last Updated: 09/26/2026